We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$31.7B
AUM Growth
+$976M
Cap. Flow
+$2.12B
Cap. Flow %
6.69%
Top 10 Hldgs %
37.46%
Holding
683
New
113
Increased
294
Reduced
197
Closed
68

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$353M
2
UBER icon
Uber
UBER
+$325M
3
AVGO icon
Broadcom
AVGO
+$320M
4
TMO icon
Thermo Fisher Scientific
TMO
+$196M
5
USB icon
US Bancorp
USB
+$141M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$128M
2
KO icon
Coca-Cola
KO
+$120M
3
META icon
Meta Platforms (Facebook)
META
+$101M
4
GSK icon
GSK
GSK
+$73.7M
5
DGX icon
Quest Diagnostics
DGX
+$43.1M

Sector Composition

Rank Sector Weight
1 Technology 29.69%
2 Healthcare 26%
3 Financials 11.57%
4 Communication Services 9.28%
5 Consumer Discretionary 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.8B 5.66%
4,783,085
+866,208
+22% +$353M
AAPL icon
2
Apple
AAPL
$4.72T
$1.49B 4.68%
6,685,574
+371,582
+6% +$86.1M
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$3.89T
$1.21B 3.82%
7,833,961
+452,043
+6% +$82M
META icon
4
Meta Platforms (Facebook)
META
$1.54T
$1.19B 3.75%
2,065,452
-156,805
-7% -$101M
UNH icon
5
UnitedHealth
UNH
$385B
$1.17B 3.67%
2,224,346
+153,378
+7% +$78.4M
JNJ icon
6
Johnson & Johnson
JNJ
$624B
$1.13B 3.56%
6,812,787
+452,544
+7% +$70.8M
ABT icon
7
Abbott
ABT
$175B
$1.08B 3.39%
8,107,583
+210,644
+3% +$26.8M
V icon
8
Visa
V
$669B
$1.04B 3.29%
2,974,829
+17,900
+0.6% +$6.06M
ELV icon
9
Elevance Health
ELV
$82.3B
$939M 2.96%
2,158,991
+158,331
+8% +$63.6M
ORCL icon
10
Oracle
ORCL
$346B
$848M 2.67%
6,064,857
+182,864
+3% +$29.8M
TXN icon
11
Texas Instruments
TXN
$260B
$818M 2.58%
4,550,245
+261,089
+6% +$48.9M
ACN icon
12
Accenture
ACN
$84.9B
$761M 2.4%
2,439,748
+208,461
+9% +$73.6M
TMO icon
13
Thermo Fisher Scientific
TMO
$213B
$725M 2.28%
1,456,080
+362,214
+33% +$196M
CRM icon
14
Salesforce
CRM
$129B
$716M 2.26%
2,666,810
+443,897
+20% +$138M
USB icon
15
US Bancorp
USB
$98.7B
$675M 2.13%
15,983,454
+3,047,607
+24% +$141M
AMZN icon
16
Amazon
AMZN
$2.51T
$654M 2.06%
3,435,972
+219,369
+7% +$47.6M
LRCX icon
17
Lam Research
LRCX
$400B
$625M 1.97%
8,593,334
+495,669
+6% +$39M
WFC icon
18
Wells Fargo
WFC
$261B
$602M 1.9%
8,381,408
-347,950
-4% -$26.1M
MRK icon
19
Merck
MRK
$322B
$600M 1.89%
6,686,596
+521,325
+8% +$48.7M
OTIS icon
20
Otis Worldwide
OTIS
$27.2B
$564M 1.78%
5,460,836
+301,731
+6% +$29.5M
KO icon
21
Coca-Cola
KO
$349B
$548M 1.73%
7,656,489
-1,804,179
-19% -$120M
ISRG icon
22
Intuitive Surgical
ISRG
$119B
$532M 1.68%
1,073,740
+10,270
+1% +$5.68M
CI icon
23
Cigna
CI
$75.7B
$523M 1.65%
1,588,863
+110,096
+7% +$33.2M
STZ icon
24
Constellation Brands
STZ
$22.1B
$483M 1.52%
2,632,951
+178,693
+7% +$32.5M
TJX icon
25
TJX Companies
TJX
$170B
$460M 1.45%
3,778,404
+4,481
+0.1% +$544K
1
2 3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2025 Portfolio in Review

As of Q1 2025, Grantham, Mayo, Van Otterloo & Co (GMO) held 683 positions worth $31.7B, up 3.2% from $30.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) deployed $2.12B of net new capital in Q1 2025, opening 113 new positions and adding to 294 existing holdings. Its largest new stake was Uber: 4,504,427 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Coca-Cola, an estimated $120M trimmed.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2025 buy was Uber: 4,504,427 shares worth $328M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Microsoft in Q1 2025, an estimated $353M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2025 reduction was Coca-Cola, cutting an estimated $120M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $128M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 37% of its $31.7B portfolio in Q1 2025.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 113 new positions and closed 68 in Q1 2025.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 3.2% quarter-over-quarter to $31.7B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2025, filed 14 May 2025.